1 - Giulia Giordano 
2 - Franco Blanchini 
3 - Raffaele Bruno 
4 - Raffaele Bruno 
5 - Patrizio Colaneri 
6 - Patrizio Colaneri 
7 - 15,887 deaths of people 
8 - 26 February 2020 
9 - 8 March 2020 
10 - Chinese data 
11 - 2.0 to 3.5 
12 - SARS-CoV 
13 - MERS-CoV 
14 - influenza viruses 
19 - SIR model
1. 1,133,758 total cases and 62,784 deaths worldwide4
2. 691,461 nasal swabs as of 5 April 2020
3. 128,948 detected cases
4. 91,246 currently infected
5. 28,949 hospitalized
6. 3,977 admitted to intensive care units (ICUs)
7. 58,320 quarantined at home
8. 21,815 discharged due to recovery
9. 15,887 had died7
10. R0 for SARS-CoV-2 ranges from 2.0 to 3.511–13
19 SIR model
20 Lin and colleagues extended a SEIR (susceptible, exposed, infectious, removed) model
21 Anastassopoulou and colleagues proposed a discrete-time SIR model
22 Casella developed a control-oriented SIR model
23 Wu and colleagues used transmission dynamics to estimate the clinical severity of COVID-19
24 Stochastic transmission models
25 Stochastic transmission models
26 Gumel and colleagues for SARS
70,000 people could die in Italy in the first year
25,000 people overall
20 February 2020 (day 1)
5 April 2020 (day 46)
9 March 2020
2.38 (basic reproduction number)
1.66 (result of the introduction of basic social distancing)
1.80 (screening focused on symptomatic individuals)
R0 = 2.38 (basic reproduction number on day 1)
R0 = 1.66 (result of introduction of basic social distancing on day 4)
R0 = 1.80 (screening focused on symptomatic individuals on day 12)
R0 = 1.60 (effectiveness of partially incomplete lockdown on day 22)
28 - day 28
0.99 - R0 = 0.99
38 - day 38
0.85 - R0 = 0.85
50 - day 50
350 - 350 days
0.12% - 0.12% of the population
35% - 35%
46 - day 46
0.61% - 0.61% of the population
0.45% - 0.45%
0.06% - 0.06% of the population
19 - day 19
50 - day 50
0.19% - 0.19% of the population
56 - day 56
0.17% - 0.17% of the population
9.8% - actual case fatality rate (CFR)
13% - perceived CFR
22 - day 22
0.52%: of the population would contract the virus (0.41% diagnosed)
0.05%: would die
857: Predicted epidemic evolution: actual vs diagnosed cases a b of infection 0.015 Cumulative infected Current total infected ) ) Recovered n n o o Deaths i i t t Diagnced cumulative infected a a l l Diagnced current total infected u u Diagnced recovered p p o o
0.015: Cumulative infected
0.010: Current total infected
0.005: Recovered
0.010: Deaths
0.8: Infected ND AS
0.6: Infected D AS
0.4: Infected ND S
0.2: Infected D S
1.0: Infected D IC
None
Performing an insufficient number of tests underestimates the transmission rate and overestimates the CFR.
33 - insufficient number of ICUs
15 min - test to detect SARS-CoV-2 immunoglobulins IgM and IgG simultaneously in human blood
30 - laboratories are moving in this direction
858 - total number of infected individuals and ICU admissions
None
3. Guan, W.-J.et al. Clinical characteristics of coronavirus disease 2019 in China.
4. WHO. Coronavirus Disease 2019 (COVID-19): Situation Report 76
5. Remuzzi, A. & Remuzzi, G. COVID-19 and Italy: what next? Lancet Health
6. Giuffrida, A. & Beaumont, P. Coronavirus: inquiry opens into hospitals at
7. Ministero della Salute (Italian Ministry of Health). http://www.salute.gov.it/
10. Wang, Y., Wang, Y., Chen, Y. & Quin, Q. Unique epidemiological and clinical features of the emerging 2019 novel coronavirus pneumonia (COVID-19) implicate special control measures. J. Med. Virol. 92, 568–576 (2020).
11. Fisman, D., Rivers, C., Lofgren, E. & Majumder, M. S. Estimation of MERS-Coronavirus reproductive number and case fatality rate for the S
12. Zhao, S. et al. Preliminary estimation of the basic reproduction number of novel coronavirus (2019-nCoV) in China, from 2019 to 2020: a data-driven analysis in the early phase of the outbreak.
13. Read, J., Bridgen, J. R., Cummings, D. A. T., Ho, A. & Jewell, C. P. Novel coronavirus 2019-nCoV: early estimation of epidemiological parameters and epidemic predictions.
14. Zou, L. et al. SARS-CoV-2 viral load in upper respiratory specimens of infected patients.
15. Anderson, R. M. & May, R. M. Infectious Diseases of Humans
16. Diekmann, O. & Heesterbeek, J. A. P. Mathematical Epidemiology of Infectious Diseases: Model Building, Analysis and Interpretation
17. Hethcote, H. W. The mathematics of infectious diseases.
18. Brauer, F. & Castillo-Chavez, C. Mathematical Models in Population Biology and Epidemiology 2nd edn
19. Kermack, W. O. & McKendrick, A
• µ and ν respectively denote the rate at which undetected and detected infected subjects develop life-threatening symptoms; 
• τ denotes the mortality rate (for infected subjects with life-threatening symp- toms) 
• λ, κ, ξ, ρ and σ denote the rate of recovery for the five classes of infected sub- jects; 
None
44 - China
45 - COVID-19-positive individuals
46 - Italy
47 - home isolation guidelines
48 - COVID-19 clusters
49 - COVID-19 clusters
50 - COVID-19 clusters
51 - median serial interval values for COVID-19
52 - median incubation period
9 - (13)
17
18
19
20
21
22
None
20 February 2020 (day 1)
5 April 2020 (day 46)
60 million
0
ρD
ϕð
ξR
σT
R0
200/60e6 - fraction of the population in each stage at day 1
20/60e6 - fraction of the population in each stage at day 1
1/60e6 - fraction of the population in each stage at day 1
2/60e6 - fraction of the population in each stage at day 1
0 - fraction of the population in each stage at day 1
0 - fraction of the population in each stage at day 1
0 - fraction of the population in each stage at day 1
0.570 - α
0.011 - β, δ
0.456 - γ
0.171 - ε
0.371 - θ
0.125 - ζ, η
0.017 - μ
0.027 - ν
0.01 - τ
0.034 - λ, ρ
0.017 - κ, ξ, σ
2.38 - R0
0.422 - α
0.0057 - β, δ
0.285 - γ
0.143 - ε
1.66 - R0
1.80 - R0
0.360 - α
0.005
α = 0.422, γ = 0.285, β = δ = 0.0057, R0 = 1.66
α = 0.252, R0 = 0.98
α = 0.105, R0 = 0.50
ε = 0.400, R0 = 0.59
α = 0.420, ε = 0.600, R0 = 0.77
CFR = 7.2%, perceived CFR = 9.0%
73% of the population contracted the virus
~64% diagnosed
~5.2% of the population died
Peak of concurrently infected individuals ~44% of the population
Peak of concurrently diagnosed infected individuals ~39% of the population
16.5% of the population
107 days
0.285 and γ = 0.171, hence R0 = 1.13
35% of the population
~30% have been diagnosed
5.3% of the population
α = 0.200 and γ = 0.086, hence R0 = 0.787
None
0.092% of the population; 
0.083% of the population; 
0.25% of the population 
~0.22% have been diagnosed 
~0.02% of the population have died 
0.04% of the population 
0.057% of the population 
0.048% of the population 
0.086% of the population 
~0.074% have been diagnosed 
~0.006% of the population have died 
0.02% of the population
α
Extended Data Fig. 4

β
Extended Data Fig. 5

γ
Extended Data Fig. 6

δ
Extended Data Fig. 7

ε
Extended Data Fig. 8

θ
Extended Data Fig. 9

ζ
Extended Data Fig. 10

η
Extended Data Fig. 10

μ
Extended Data Fig. 10

ν
Extended Data Fig. 10

λ
Extended Data Fig. 10

ρ
Extended Data Fig. 10

κ
Extended Data Fig. 10

ξ
Extended Data Fig. 10

σ
Extended Data Fig. 10

τ
Extended Data Fig. 10
Fig. 3
Code availability
38. Epidemiologist: ‘Too early to say’ if infected people develop immunity from the coronavirus (interview to David Heymann)
39. Chen, D. et al. Recurrence of positive SARS-CoV-2 RNA in COVID-19: a case report.
40. Zhou, L. et al. Cause analysis and treatment strategies of ‘recurrence’ with novel coronavirus pneumonia (covid-19) patients after discharge from hospital.
41. Houser, K. V. et al. Enhanced inflammation in New Zealand white rabbits when MERS-CoV reinfection occurs in the absence of neutralizing antibody.
42. Hemida, M. G. et al. Longitudinal study of middle east respiratory syndrome coronavirus infection in dromedary camel herds in Saudi Arabia, 2014–2015.
43. Subbarao, K. et al. Prior infection and passive transfer of neutralizing antibody prevent replication of severe acute respiratory syndrome coronavirus in the respiratory tract of mice.
44. Ji, N.-L. et al. Clinical features of pediatric patients with COVID-
46. Fineberg, H. V. Ten weeks to crush the curve. N. Engl. J. Med. https://doi.org/10.1056/NEJMe2007263 (2020).
47. Istituto Superiore di Sanità. Recommendations for People in Family Isolation and Their Caregivers http://www.salutfor exampleov.it/portale/nuovocoronavirus/dettaglioNotizieNuovoCoronavirus.jsp?lingua=italiano&menu=notizie&p=dalministero&id=4266 (accessed 4 April 2020).
48. Pung, R. et al. Investigation of three clusters of COVID-19 in Singapore: implications for surveillance and response measures. Lancet 395, 1039–1046 (2020).
49. Rothe, C. et al. Transmission of 2019-nCoV infection from an asymptomatic contact in Germany. N. Engl. J. Med. 382, 970–971 (2020).
50. Kimball, A. et al. Asymptomatic and presymptomatic
